206 related articles for article (PubMed ID: 1824742)
1. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
Nuttall GA; Murray MJ; Bowie EJ
Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
[TBL] [Abstract][Full Text] [Related]
2. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
Schumacher WA; Heran CL; Ogletree ML
Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
[TBL] [Abstract][Full Text] [Related]
4. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.
Ghuysen A; Lambermont B; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Magis D; Hanson J; Segers P; D'Orio V
J Pharmacol Exp Ther; 2004 Sep; 310(3):964-72. PubMed ID: 15121765
[TBL] [Abstract][Full Text] [Related]
5. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
Stefaniszyn HJ; Novick RJ; Salerno TA
J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine.
Hobbhahn J; Conzen PF; Zenker B; Goetz AE; Peter K; Brendel W
Anesth Analg; 1988 Mar; 67(3):253-60. PubMed ID: 3125765
[TBL] [Abstract][Full Text] [Related]
8. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
Kopia GA; Kopaciewicz LJ; Ohlstein EH; Horohonich S; Storer BL; Shebuski RJ
J Pharmacol Exp Ther; 1989 Sep; 250(3):887-95. PubMed ID: 2528630
[TBL] [Abstract][Full Text] [Related]
9. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
Rogers K; Milne B; Salerno TA
J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil activation mediates protamine-induced pulmonary hypertension.
Cho PW; Gillinov AM; Zehr KJ; Burch RM; Winkelstein JA; Cameron DE
J Surg Res; 1993 May; 54(5):486-93. PubMed ID: 8103132
[TBL] [Abstract][Full Text] [Related]
11. Heparin-protamine complexes cause pulmonary hypertension in goats.
Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
Anesthesiology; 1995 Oct; 83(4):786-91. PubMed ID: 7574058
[TBL] [Abstract][Full Text] [Related]
12. Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
Freitas CF; Morganti RP; Annichino-Bizzacchi JM; De Nucci G; Antunes E
Clin Exp Pharmacol Physiol; 2007; 34(1-2):10-4. PubMed ID: 17201729
[TBL] [Abstract][Full Text] [Related]
13. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
Morel DR; Costabella PM; Pittet JF
Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
Fiser WP; Fewell JE; Hill DE; Barnes RW; Read RC
J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
[TBL] [Abstract][Full Text] [Related]
15. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb.
Kurrek MM; Winkler M; Robinson DR; Zapol WM
Anesthesiology; 1995 Jan; 82(1):183-7; discussion 31A. PubMed ID: 7832299
[TBL] [Abstract][Full Text] [Related]
16. Effect of leukopenia on pulmonary hypertension after heparin-protamine in pigs.
Habazettl H; Conzen PF; Vollmar B; Yekebas E; Peter K
J Appl Physiol (1985); 1992 Jul; 73(1):44-9. PubMed ID: 1506397
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep.
Montalescot G; Lowenstein E; Ogletree ML; Greene EM; Robinson DR; Hartl K; Zapol WM
Circulation; 1990 Nov; 82(5):1765-77. PubMed ID: 2146041
[TBL] [Abstract][Full Text] [Related]
18. Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity.
Wakefield TW; Whitehouse WM; Stanley JC
J Vasc Surg; 1984 Mar; 1(2):346-55. PubMed ID: 6481883
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.
DeLucia A; Wakefield TW; Andrews PC; Nichol BJ; Kadell AM; Wrobleski SK; Downing LJ; Stanley JC
J Vasc Surg; 1993 Jul; 18(1):49-58; discussion 58-60. PubMed ID: 8326659
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension after heparin-protamine: roles of left-sided infusion, histamine, and platelet-activating factor.
Habazettl H; Conzen PF; Vollmar B; Yekebas E; Gutmann R; Hobbhahn J; Brendel W; Peter K
Anesth Analg; 1990 Dec; 71(6):637-44. PubMed ID: 2240637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
